Tadalafil for Lung Pressure, and Whether It Can Be Used for Erectile Dysfunction

Tadalafil turns up in two completely different corners of UK medicine.

In one, it is a daily tablet for a serious, progressive condition affecting the arteries in the lungs, called pulmonary arterial hypertension. In the other, it is an on-demand or low-dose daily tablet for erectile dysfunction.

Same molecule, same class of phosphodiesterase type 5 inhibitors. But two different licences, two different licensed populations, two different regimens, and two very different clinical conversations.

That overlap creates a predictable question. If the active ingredient is identical, can a tablet licensed for lung pressure be used for erection problems instead? People ask because they have compared the two on paper and concluded the difference is marketing, or because someone in the household already has one in a cupboard.

The short answer is no, and this page sets out why rather than leaving it as an instruction. It covers what the lung pressure licence says, why tablet appearance is a poor safety check, and what a properly licensed route for erectile dysfunction looks like.

Key things to know

• Tadalafil holds separate UK marketing authorisations for pulmonary arterial hypertension and for erectile dysfunction. A licence covers a specific condition, population and regimen, not the ingredient in isolation
• The pulmonary arterial hypertension licence covers adults and children aged 2 and over, with children's doses based on age and weight
• Using a pulmonary arterial hypertension product to treat erectile dysfunction would be outside its licensed use, and the two regimens are not interchangeable
• The nitrate contraindication applies to every tadalafil product, whichever licence it sits under
• Treatment suitability depends on an individual clinical assessment, particularly with cardiovascular disease or other medicines involved

One Active Ingredient, Two Marketing Authorisations

A UK marketing authorisation is not permission to sell a chemical. It is permission to sell a specific finished product, in a specific form and strength, for a specific condition, in a specific group of people, supported by evidence the regulator assessed.

That is why tadalafil exists twice. The evidence for its use in pulmonary arterial hypertension is separate from the evidence for erectile dysfunction: separate trials, separate endpoints, separate safety monitoring and separate populations. The regulator did not assess one and infer the other.

Why the Class Is the Same but the Products Are Not

Tadalafil belongs to the PDE5 inhibitor class, alongside sildenafil, vardenafil and avanafil. All of them block the enzyme that breaks down a signalling molecule called cGMP. Leave more cGMP in place and the smooth muscle in blood vessel walls relaxes.

In erectile dysfunction, that relaxation lets the vessels supplying the erectile tissue fill more readily. In pulmonary arterial hypertension, the same effect acts on the blood vessels of the lungs, lowering resistance and reducing the pressure the right side of the heart has to work against.

Those are two different circulations with two different clinical objectives. One aims to produce an effect when needed and then let it pass. The other aims to hold a sustained change in a circulation under permanent strain. A regimen built for the second is not a convenient version of the first.

What the Lung Pressure Licence Covers

Pulmonary arterial hypertension means abnormally high pressure in the arteries carrying blood from the heart to the lungs. It is uncommon and serious, and is managed by specialist services rather than general practice, with long-term follow-up on how the right side of the heart is coping.

Regulator safety material describing the two licences is explicit about the difference. The pulmonary product is authorised for adults and children with pulmonary arterial hypertension. The erectile dysfunction product is for men with erectile dysfunction, and is not indicated for women.

That contrast is worth reading twice. The pulmonary licence extends to children because that is what the evidence supported. The erectile dysfunction licence does not, because the condition and the evidence base are different. These are not two labels on the same box.

What the Licence Does Not Say

A pulmonary arterial hypertension licence says nothing about erectile function. The evidence for tadalafil in erectile dysfunction belongs to the erectile dysfunction licence and its own dosing.

Anyone reasoning that a specialist medicine must be a stronger version of a general one has the logic backwards. The pulmonary regimen is not stronger. It is designed to act continuously on a different circulation, in people whose cardiovascular system is already under strain, with specialist monitoring built around it.

That monitoring covers things that cannot be estimated at home, including dose adjustments for liver or kidney impairment, where exposure to the medicine increases, and interactions with other medicines such as certain HIV treatments, blood pressure medicines and bosentan.

What Off-Licence Use Changes

Off-licence use is not a technicality. It changes three practical things at once.

The guidance stops fitting. The product information still describes the medicine's known risks and interactions, but it gives no guidance for a use it was not licensed for.

The assessment stops applying. A licensed supply comes with a prescriber who checked your medicines, blood pressure and cardiovascular history against that specific use. Without it, those things may go unchecked.

Reporting gets harder. Suspected side effects can be reported through the MHRA Yellow Card scheme, but a report is only useful if what was taken, and why, is known.

Start Your Free Assessment

The Plain Answer on Repurposing a Lung Pressure Tablet

A pulmonary arterial hypertension tadalafil product should not be used on your own initiative to treat erectile dysfunction. The active ingredient is the same, but the licensed indication, regimen and clinical context are different, and any use outside the licence is a decision for a prescriber after an individual assessment.

This is worth stating without hedging, because the hedged version does real harm. A page that says the ingredient is the same and leaves it there sounds like permission. The reasons are specific, and they are not about brand protection.

Three Reasons the Answer Stays No

The regimen is built for a different goal. The pulmonary regimen is a regular once-daily treatment for the ongoing management of a lung condition, not a regimen chosen around anticipated sexual activity.

Nobody is monitoring. Pulmonary arterial hypertension treatment sits inside a specialist service with structured review. Take the same product for an unrelated purpose and none of that exists. Nothing checks whether blood pressure has drifted, whether an interacting medicine has been added, or whether the erectile difficulty is signalling something else.

Erectile dysfunction is often an early cardiovascular signal. A proper consultation asks about cardiovascular risk, blood pressure and other medicines precisely because the symptom sometimes arrives before the diagnosis. Self-treating with a tablet from a cupboard skips the one conversation most worth having.

How the Two Licensed Uses Compare

The only row where the two are identical is the nitrate contraindication, because that follows the molecule rather than the licence.

Nitrates and the Warning That Follows the Molecule

Every tadalafil product carries a contraindication with nitrates and nitric oxide donors, and it applies identically whether the tablet was dispensed for lung pressure or erectile dysfunction.

Nitrates are used for angina and some other heart conditions, and include glyceryl trinitrate tablets, sprays and patches, isosorbide mononitrate and isosorbide dinitrate. Nicorandil and amyl nitrite act through the same pathway. Combined with a PDE5 inhibitor, the blood-pressure-lowering effects compound and can cause a severe drop, with fainting, collapse and heart complications.

Anyone using nitrates should not take any PDE5 inhibitor. Our guide to what to avoid with PDE5 inhibitors is worth reading before any first tablet.

Other Cautions That Apply to the Class

Uncontrolled high blood pressure, very low blood pressure, a recent stroke or heart attack, and previous loss of vision in one eye from a condition called NAION all require assessment before any product in this class is considered. Some antifungals, antibiotics and medicines for blood pressure or prostate symptoms also change how tadalafil behaves in the body.

Liver and kidney function matter too, because both organs help clear the medicine. Reduced function can mean it lingers, which is a prescriber's judgement rather than something to estimate at home. Mention any known liver or kidney condition at assessment rather than assuming it is minor.

For daily regimens, never double up to make up for a missed tablet. It does not compensate for anything, and it increases the risk of side effects.

None of that can be worked out from a leaflet belonging to a different licence.

Tablet Appearance Is Not a Safety Check

A recurring pattern is people trying to identify a tablet by its shape, colour or imprint, then reasoning from the answer.

Appearance is a poor tool for this. Colour, shape and markings are chosen by each manufacturer, generic versions of the same medicine routinely look nothing alike, and nothing requires products with the same active ingredient to resemble each other. No public UK service lets you confirm an unlabelled tablet from a photograph.

More importantly, appearance is exactly what falsified products imitate. Illegally traded tablets are made to look convincing, because looking convincing is the whole business model. MHRA enforcement found seized products containing sildenafil, tadalafil, vardenafil and avanafil, and warns that such products may contain no active ingredient, the wrong dose, hidden medicines or toxic ingredients.

Between 2021 and 2025 the MHRA seized around 19.5 million doses of illegally traded erectile dysfunction pills, including 4.4 million in 2025 alone. Its advice is to use only UK-registered pharmacies, including online pharmacies displaying the official green cross logo.

Start Your Free Assessment

How Tadalafil Is Supplied in the UK

Most tadalafil products are prescription-only medicines. The exception is Cialis Together 10mg, a pharmacy medicine that can be supplied for erectile dysfunction following a pharmacist's assessment.

Either way, there is no legitimate supply that skips a professional assessment. A supplier offering tadalafil of any kind with no prescribing or pharmacist check is not operating legally, whichever condition the product is licensed for.

Pulmonary arterial hypertension products are supplied through specialist services. That pathway is not open to someone seeking a medicine for a different reason, and it is not meant to be.

Checking That a Supplier Is Genuine

Three checks settle it:

1. Find the registration number. Look for a GPhC registration number and check it on the regulator's register. EveryDayMeds is registered with the General Pharmaceutical Council, number 9012878
2. Confirm there is a real prescribing step. GPhC guidance requires prescribers to prescribe only with adequate knowledge of your health, and not on a questionnaire alone
3. Check you can reach a person. A legitimate service can be contacted, and will decline a request when declining is the right answer

Treat medicines offered through social media, messaging apps or marketplace listings with particular caution, especially where there is no verifiable pharmacy registration or assessment.

The Licensed Route for Erectile Dysfunction

If the reason for reading this page is an erection problem rather than an interest in lung medicine, the route is straightforward.

Tadalafil and sildenafil are both licensed options, and they behave differently. Tadalafil taken as needed can remain effective for up to 36 hours and is usually taken at least 30 minutes beforehand, which suits people who prefer not to plan around a narrow window. Sildenafil tablets have a shorter, more defined window and are more affected by a heavy meal beforehand.

Neither is better in the abstract. They suit different circumstances, and which fits you is a conversation to have with a prescriber rather than a decision to make from a comparison table.

The full range of licensed erectile dysfunction treatments shows what is available. Orders are dispatched in plain unbranded packaging, as early as the next working day when placed before the cut-off, to a home address or a local collection point. Results vary between individuals.

What Could Not Be Verified

• The current UK marketing status of individual branded pulmonary arterial hypertension products could not be confirmed from regulator sources at the time of writing. Brand availability changes, and an unconfirmed claim either way would be worse than none
• No public UK database lets a member of the public identify an unlabelled tablet from its appearance

Start Your Free Assessment